Alternative Splicing of Bcap (PIK3AP1) Enhances Oncogenic Signaling in Subsets of Activated B-Cell Diffuse Large B-Cell Lymphoma

被引：0
|
作者：
Itsara, Andy [1 ]
Scheich, Sebastian [2 ]
Haeupl, Bjoern [3 ,4 ,5 ,6 ]
Yu, Xin [2 ]
Oellerich, Thomas [3 ,4 ,5 ,6 ]
Staudt, Louis M. [2 ]
机构：
[1] NHLBI, Hematol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA
[2] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[3] German Canc Res Ctr, Heidelberg, Germany
[4] German Canc Consortium, Heidelberg, Germany
[5] Goethe Univ, Dept Med 2, Hematol Oncol, Frankfurt, Germany
[6] Goethe Univ, Frankfurt Canc Inst, Frankfurt, Germany
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-163619
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6394 / 6395
页数：2
相关论文
共 50 条
  • [21] Diffuse large B-cell lymphoma
    Alcantara, Marion
    Huynh, Tony
    HEMATOLOGIE, 2016, 22 (02): : 159 - 166
  • [22] Oncogenic Mutational Disruption of KLHL6 Dimers Fuels B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma
    Meriranta, Leo
    Sorri, Selma
    Zafar, Sadia
    Liu, Xiaonan
    Sahlberg, Eerika
    Dufva, Olli
    Goos, Helka
    Karjalainen-Lindsberg, Marja-Liisa
    Varjosalo, Markku
    Hyytiainen, Marko
    Leppa, Sirpa
    BLOOD, 2022, 140 : 5889 - 5890
  • [23] B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma
    Ci, Weimin
    Polo, Jose M.
    Melnick, Ari
    CURRENT OPINION IN HEMATOLOGY, 2008, 15 (04) : 381 - 390
  • [24] Breast Diffuse Large B-cell Lymphoma, Activated B-cell like Subtype: A Case Report
    Babaria, Sneha samir
    Patel, JINAlBEN SHAIlESHBHAI
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2025, 19 (01) : ED1 - ED3
  • [25] Imbalance in Alternative Splicing of MCL-1 Inhibits Apoptosis in Diffuse Large B-Cell Lymphoma
    Rekers, Nicolle H.
    Moesbergen, Laura M.
    Hijmering, Nathalie J.
    Vos, Wim
    Oudejans, Joost
    Ossenkoppele, Gert J.
    Meijer, Chris J. L. M.
    Cillessen, Saskia A. G. M.
    BLOOD, 2014, 124 (21)
  • [26] Unclassifiable B-cell lymphoma: Between diffuse large B-cell lymphoma and Burkitt lymphoma
    Mandi, Y.
    Malihy, A.
    Kettani, F.
    Alaammari, I.
    Khmou, M.
    Touri, S.
    Rouas, L.
    Lamalmi, N.
    El Khorassani, M.
    Alhamany, Z.
    ARCHIVES DE PEDIATRIE, 2015, 22 (06): : 661 - 664
  • [27] Antigen-Independent, Autonomous B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma
    Eken, Janneke A.
    Koning, Marvyn T.
    Yanez, Julieta H. Sepulveda
    van Bergen, Cornelis A. M.
    Quinten, Edwin
    Kupcova, Kristyna
    Havranek, Ondrej
    De Groen, Ruben A. L.
    Vermaat, Joost S. P.
    de Jong, Daphne
    Kluin, Philip
    Cleven, Arjen
    Jumaa, Hassan
    Veelken, Hendrik
    BLOOD, 2022, 140 : 6444 - 6445
  • [28] Targeting the B-cell receptor pathway in diffuse large B-cell lymphoma
    Dunleavy, Kieron
    Erdmann, Tabea
    Lenz, Georg
    CANCER TREATMENT REVIEWS, 2018, 65 : 41 - 46
  • [29] B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma: Tonic Alone in the Germinal Center B-Cell Subtype, Plus Self Antigen-Induced in the Activated B-Cell Subtype
    Havranek, Ondrej
    Koehrer, Stefan
    Xu, Jingda
    Becker, Lisa
    Comer, Justin M.
    Karri, Anusha R.
    Wang, Zhiqiang
    Ma, Wencai
    Westin, Jason R.
    Zal, Tomasz
    Burger, Jan A.
    Davis, R. Eric
    BLOOD, 2015, 126 (23)
  • [30] Cutaneous diffuse large B-cell lymphoma, leg type, secondary to testicular diffuse large B-cell lymphoma
    Pampin, A.
    Gomez-de la Fuente, E.
    Feltes, R. A.
    Pinedo, F.
    Rodriguez-Peralto, J. L.
    Lopez-Estebaranz, J. L.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2014, 39 (02) : 230 - 232
12345